Accuri Cytometers this week announced the appointment of Dan Calvo and George Dunbar to newly created positions on its board of directors.
Dunbar is currently president, CEO, and a director of Aastrom Biosciences, a company specializing in autologous stem cell products for use in regenerative medicine.
Prior to Aastrom, Dunbar served as CEO of several life science companies including Quantum Dot Corporation, Targesome, Epic Therapeutics, Cytotherapeutics, Stem Cells, and Metra Biosystems. Earlier in his career, Dunbar held management positions with the Ares-Serono Group and Amersham International.
Calvo is currently president and CEO of Assay Designs, which provides research assays and reagents to biomedical, pharmaceutical, and translational research companies. Prior to Assay Designs, Calvo was CEO of Cellomics. Previously, Calvo held positions with PerkinElmer Life and Analytical Sciences, NEN Life Sciences, and DuPont.